Palisade Bio Inc. (PALI) EPS is poised to hit -0.61 next quarter: How Investors Can Make It Count the Most?

Witnessing the stock’s movement on the chart, on May 25, 2023, Palisade Bio Inc. (NASDAQ: PALI) had a quiet start as it plunged -8.28% to $1.33. During the day, the stock rose to $1.46 and sunk to $1.27 before settling in for the price of $1.45 at the close. Taking a more long-term approach, PALI posted a 52-week range of $1.41-$32.00.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Nevertheless, stock’s Earnings Per Share (EPS) this year is 88.70%. This publicly-traded company’s shares outstanding now amounts to $4.32 million, simultaneously with a float of $1.36 million. The organization now has a market capitalization sitting at $9.38 million. At the time of writing, stock’s 50-day Moving Average stood at $1.7810, while the 200-day Moving Average is $3.7806.

Palisade Bio Inc. (PALI) Ownership Facts and Figures

Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Palisade Bio Inc.’s current insider ownership accounts for 0.30%, in contrast to 11.00% institutional ownership. According to the most recent insider trade that took place on Sep 01, this organization’s Chief Financial Officer bought 19,481 shares at the rate of 0.14, making the entire transaction reach 2,799 in total value, affecting insider ownership by 148,727. Preceding that transaction, on Aug 23, Company’s Chief Financial Officer bought 7,350 for 0.16, making the whole transaction’s value amount to 1,176. This particular insider is now the holder of 129,246 in total.

Palisade Bio Inc. (PALI) Earnings and Revenue Records

As on 3/30/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.54 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.72) by $0.18. This company achieved a return on equity of -146.62. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.

Palisade Bio Inc.’s EPS increase for this current 12-month fiscal period is 88.70% and is forecasted to reach -1.53 in the upcoming year.

Palisade Bio Inc. (NASDAQ: PALI) Trading Performance Indicators

Let’s observe the current performance indicators for Palisade Bio Inc. (PALI). It’s Quick Ratio in the last reported quarter now stands at 10.90. The Stock has managed to achieve an average true range (ATR) of 0.16. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 31.26.

In the same vein, PALI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -12.48, a figure that is expected to reach -0.61 in the next quarter, and analysts are predicting that it will be -1.53 at the market close of one year from today.

Technical Analysis of Palisade Bio Inc. (PALI)

Going through the that latest performance of [Palisade Bio Inc., PALI]. Its last 5-days volume of 1.97 million indicated improvement to the volume of 1.45 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 26.52% While, its Average True Range was 0.1565.

Raw Stochastic average of Palisade Bio Inc. (PALI) in the period of the previous 100 days is set at 1.77%, which indicates a major fall in contrast to 9.68% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 63.02% that was lower than 151.86% volatility it exhibited in the past 100-days period.